Reveal meaningful cancer-related signals at the earliest detectable stages — even before conventional tools can identify abnormalities.
A simple, routine blood draw with no discomfort, preparation, or recovery time.
Provides cellular-level information that fills the gaps left by imaging, markers, or routine checkups.
Adults over 40 or with elevated risk
Showing unclear abnormalities on routine tests
Currently undergoing cancer treatment or receiving post-treatment follow-up
Feeling unwell but standard tests remain inconclusive
Where to Access Testing？
Our diagnostic service is currently available across Taiwan, with international locations coming soon.
You can view the list of partner labs before booking. Once your appointment is confirmed, you’ll be able to schedule your blood draw at the lab that’s most convenient for you.
Your Report Includes：
- Whether CTCs were detected in your blood.
- The number and type of CTCs (single cells, clusters).
- What these results may mean for your risk assessment.
- Recommendations for follow-up with your physician.
Important: CTC testing is not a replacement for imaging or medical checkups. Results should always be interpreted by a qualified healthcare professional.
CASE 1
Routine checkups showed no signs of cancer, though imaging suggested a small liver shadow and blood marker AFP was only slightly elevated. CTC testing flagged high risk with CTC clusters and revealed PD-L1 expression, leading to immunotherapy treatment. Follow-up CTC tests showed clusters shrinking and nearly disappearing — a response invisible to scans but clear through CTCs.
CASE 2
A 21 mm lung nodule was found on low-dose CT, but CTC testing showed no circulating tumor cells. With no signs of active disease, the patient avoided unnecessary procedures and will return for follow-up in one year to monitor the nodule.
CASE 3
A patient newly diagnosed with pancreatic cancer started chemotherapy. While scans showed the tumor shrinking, CTC testing confirmed a dramatic drop in circulating tumor cells — providing real-time evidence that treatment was working and offering a way to monitor recurrence risk before and after surgery.